Protect Pharmaceutical (PRTT) Stock Statistics & Valuation Metrics
Total Valuation
Protect Pharmaceutical has a market cap or net worth of $3.33M. The enterprise value is -$9.32T.
- Market Cap
- $3.33M
- Enterprise Value
- -$9.32T
Share Statistics
Protect Pharmaceutical has 57,451,378 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 57,451,378
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Protect Pharmaceutical’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 16.74%.
- Return on Equity (ROE)
- 0.17
- Return on Assets (ROA)
- 0.13
- Return on Invested Capital (ROIC)
- 16.74%
- Return on Capital Employed (ROCE)
- 0.17
- Revenue Per Employee
- 220.44K
- Profits Per Employee
- 93.88K
- Employee Count
- 600
- Asset Turnover
- 0.32
- Inventory Turnover
- 0.50
Valuation Ratios
The current PE Ratio of Protect Pharmaceutical is -154.99. Protect Pharmaceutical’s PEG ratio is 1.55.
- PE Ratio
- -154.99
- PS Ratio
- 0.00
- PB Ratio
- 0.01
- Price to FCF
- -0.73
- Price to Operating Cash Flow
- -1.59
- PEG Ratio
- 1.55
Income Statement
In the last 12 months, Protect Pharmaceutical had revenue of 132.26M and earned 56.33M in profits. Earnings per share was 0.98.
- Revenue
- 132.26M
- Gross Profit
- 72.56M
- Operating Income
- 57.64M
- Pretax Income
- 57.64M
- Net Income
- 56.33M
- EBITDA
- 57.64M
- Earnings Per Share (EPS)
- 0.98
Cash Flow
In the last 12 months, operating cash flow was 6.18M and capital expenditures -3.49M, giving a free cash flow of 2.69M billion.
- Operating Cash Flow
- 6.18M
- Free Cash Flow
- 2.69M
- Free Cash Flow per Share
- -0.08
Dividends & Yields
Protect Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -137.15%
- Earnings Yield
- -0.65%
Stock Price Statistics
- Beta
- 0.39
- 52-Week Price Change
- -69.19%
- 50-Day Moving Average
- 0.14
- 200-Day Moving Average
- 0.14
- Relative Strength Index (RSI)
- 26.59
- Average Volume (3m)
- 24.34K
Financial Position
Protect Pharmaceutical as a current ratio of 3.06, with Debt / Equity ratio of 1.15%
- Current Ratio
- 3.06
- Quick Ratio
- 1.67
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- -0.24
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Protect Pharmaceutical has paid 1.31M in taxes.
- Income Tax
- 1.31M
- Effective Tax Rate
- 0.02
Enterprise Valuation
Protect Pharmaceutical EV to EBITDA ratio is 572.55, with an EV/FCF ratio of 2.69.
- EV to Sales
- 0.00
- EV to EBITDA
- 572.55
- EV to Free Cash Flow
- 2.69
- EV to Operating Cash Flow
- 5.86
Balance Sheet
Protect Pharmaceutical has $75.76M in cash and marketable securities with $4.41M in debt, giving a net cash position of $71.36M billion.
- Cash & Marketable Securities
- $75.76M
- Total Debt
- $4.41M
- Net Cash
- $71.36M
- Net Cash Per Share
- $1.24
- Tangible Book Value Per Share
- $5.94
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Protect Pharmaceutical is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―
